Low-grade glioma on stereotactic biopsy: How often is the diagnosis accurate?

Minimally Invasive Neurosurgery

Volumn 51, Issue 5, 2008, Pages 275-279

  Muragaki, Y ^a   Chernov, M ^a   Maruyama, T ^a   Ochiai, T ^a   Taira, T ^a   Kubo, O ^a   Nakamura, R ^a   Iseki, H ^a   Hori, T ^a   Takakura, K ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Diagnostic accuracy; Low grade glioma; MIB 1 index; Stereotactic biopsy

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER INCIDENCE; CANCER SURGERY; CANCER TISSUE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; RISK FACTOR; SCHOOL CHILD; STEREOTACTIC BIOPSY; TREATMENT INDICATION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; ASTROCYTOMA; BIOPSY; BRAIN; BRAIN NEOPLASMS; CHILD; DIAGNOSTIC ERRORS; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MITOTIC INDEX; NEUROSURGICAL PROCEDURES; OBSERVER VARIATION; OLIGODENDROGLIOMA; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; STEREOTAXIC TECHNIQUES; YOUNG ADULT;

EID: 55549104415     PISSN: 09467211     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1082322     Document Type: Article

References (39)

1. Chandrasoma PT, Smith MM, Apuzzo MLJ. Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen. Neurosurgery 1989; 24: 160-165
2. Revesz T, Scaravilli F, Coutinho L et al. Reliability of histological diagnosis including grading in gliomas biopsied by image-guided stereotactic technique. Brain 1993; 116: 781-793
3. Kim JE, Kim DG, Paek SR et al. Stereotactic biopsy for intracranial lesions: reliability and its impact on the planning of treatment. Acta Neurochir (Wien) 2003; 145: 547-555
4. Glantz MJ, Burger PC, Herndon JE II et al. Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology 1991; 41: 1741-1744
5. Grunert P, Ungersbock K, Bohl J et al. Results of 200 intracranial stereotactic biopsies. Neurosurg Rev 1994; 17: 59-66
6. Vaquero J, Martinez R, Manrique M. Stereotactic biopsy for brain tumors: is it always necessary? Surg Neurol 2000; 53: 432-438
7. Jackson RJ, Fuller GN, Abi-Said D et al. Limitations of stereotactic biopsy in the initial management of gliomas. Neurooncology 2001; 3: 193-200
8. MacGirt MJ, Villavicencio AT, Bulsara KR et al. MRI-guided stereotactic biopsy in the diagnosis of glioma: comparison of biopsy and surgical resection specimen. Surg Neurol 2003; 59: 277-282
9. Kleihues P, Cavenee WK, eds. Pathology and genetics of tumours of the Nervous System. Lyon: IARC Press; 2000
10. Mork SJ, Halvorsen TB, Lindegaard K-F et al. Oligodendroglioma: histologic evaluation and prognosis. J Neuropathol Exp Neurol 1986; 45: 65-78
11. Aker FV, Hakan T, Karadereler S et al. Accuracy and diagnostic yield of stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimens. Neuropathology 2005; 25: 207-213
12. Okamoto Y, Patre PL Di, Burkhard C et al. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathol (Berl) 2004; 108: 49-56
13. Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 2005; 64: 479-489
14. Krouwer HCJ, Duinen SG van, Kamphorst W et al. Oligoastrocytomas: a clinicopathological study of 52 cases. J Neuroonco] 1997; 33: 223-238
15. Grier JT, Batchelor T. Low-grade gliomas in adults. Oncologist 2006; 11: 681-693
16. Lebrun C, Fontaine D, Bourg V et al. Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapy. Eur J Neurol 2007; 14: 391-398
17. Dean BL, Drayer BP, Bird CR et al. Gliomas: classification with MR imaging. Radiology 1990; 174: 411-415
18. Law M, Yang S, Wang H et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003; 24: 1989-1998
19. Kondziolka D, Lunsford LD, Martinez AJ. Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 1993; 79: 533-536
20. Barker FG II, Chang SM, Huhn SL et al. Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer 1997; 80: 936-941
21. Ginsberg LE, Fuller GN, Hashmi M et al. The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol 1998; 49: 436-440
22. Scott JN, Brasher PMA, Sevick RJ et al. How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 2002; 59: 947-949
23. Buckner JC, Gesme D Jr, O'Fallon JR et al. Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities. J Clin Oncol 2003; 21: 251-255
24. Massager N, David P, Goldman S et al. Combined magnetic resonance imaging- and positron emission tomography-guided stereotactic biopsy in brainstem mass lesions: diagnostic yield in a series of 30 patients. J Neurosurg 2000; 93: 951-957
25. Maia ACM Jr, Malheiros SMF, da Rocha AJ et al. Stereotactic biopsy guidance in adults with supratentorial nonenhancing gliomas: role of perfusion-weighted magnetic resonance imaging. J Neurosurg 2004; 101: 970-976
26. 18F] fluoroethyl-L-tyrosine and magnetic resonance spectroscopy. J Neurosurg 2005; 102: 318-327
27. Kelly PJ, Daumas-Duport C, Kispert DB et al. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 1987; 66: 865-874
28. Plunkett R, Allison RR, Grand W. Stereotactic neurosurgical biopsy is an underutilized modality. Neurosurg Rev 1999; 22: 117-120
29. Yu X, Liu Z, Tian Z et al. Stereotactic biopsy for intracranial space-occupying lesions: clinical analysis of 550 cases. Stereotact Funct Neurosurg 2000; 75: 103-108
30. Kim L, Hochberg FH, Thornton AF et al. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for Grade III and Grade IV oligoastrocytomas. J Neurosurg 1996; 85: 602-607
31. Blaauw G, Braakman R. Pitfalls in diagnostic stereotactic brain surgery. Acta Neurochir Suppl 1988; 42: 161-165
32. Feiden W, Steude U, Bise K et al. Accuracy of stereotactic brain tumor biopsy: comparison of the histologic findings in biopsy cylinders and resected tumor tissue. Neurosurg Rev 1991; 14: 51-56
33. Soo TM, Bernstein M, Provias J et al. Failed stereotactic biopsy in a series of 518 cases. Stereotact Funct Neurosurg 1996; 64: 183-196
34. Coons SW, Johnson PC. Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index. J Neuropathol Exp Neurol 1993; 52: 609-618
35. Mittler MA, Walters BC, Stopa EG. Observer reliability in histological grading of astrocytoma stereotactic biopsies. J Neurosurg 1996; 85: 1091-1094
36. Daumas-Duport C, Scheithauer B, O'Fallon J et al. Grading of astrocytomas: a simple and reproducible method. Cancer 1988; 62: 2152-2165
37. Hemm S, Vayssiere N, Zanca M et al. Thallium SPECT-based stereotactic targeting for brain tumor biopsies. Stereotact Funct Neurosurg 2004; 82: 70-76
38. Son BC, Kim MC, Choi BG et al. Proton magnetic resonance chemical shift imaging (1 H CSI)-directed stereotactic biopsy. Acta Neurochir (Wien) 2001; 143: 45-50
39. Hall WA, Truwit CL. 1.5 T spectroscopy-supported brain biopsy. Neurosurg Clin N Am 2005; 16: 165-172